Cancers, Vol. 12, Pages 1166: Multicenter Evaluation of Independent High-Throughput and RT-qPCR Technologies for the Development of Analytical Workflows for Circulating miRNA Analysis Cancers doi: 10.3390/cancers12051166 Authors: Anna Babayan Martin H. D. Neumann Andrei Herdean Jonathan M. Shaffer Melanie Janning Franca Kobus Sonja Loges Francesca Di Pasquale Mikael Kubista Martin Schlumpberger Rita Lampignano Thomas Krahn Thomas Schlange Markus Sprenger-Haussels...
Cancers, Vol. 12, Pages 1165: Hormone Receptor-Status Prediction in Breast Cancer Using Gene Expression Profiles and Their Macroscopic Landscape Cancers doi: 10.3390/cancers12051165 Authors: Seokhyun Yoon Hye Sung Won Keunsoo Kang Kexin Qiu Woong June Park Yoon Ho Ko The cost of next-generation sequencing technologies is rapidly declining, making RNA-seq-based gene expression profiling (GEP) an affordable technique for predicting receptor expression status and intrinsic...
Cancers, Vol. 12, Pages 1163: 18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival Cancers doi: 10.3390/cancers12051163 Authors: Giulia Polverari Francesco Ceci Valentina Bertaglia Maria Lucia Reale Osvaldo Rampado Elena Gallio Roberto Passera Virginia Liberini Paola Scapoli Vincenzo Arena Manuela Racca Andrea Veltri Silvia Novello Désirée Deandreis Objectives:...
Cancers, Vol. 12, Pages 1162: Colorectal Cancer and Probiotics: Are Bugs Really Drugs? Cancers doi: 10.3390/cancers12051162 Authors: Purushottam Lamichhane Morgan Maiolini Omar Alnafoosi Sedra Hussein Hasan Alnafoosi Stewart Umbela Tayanna Richardson Nevien Alla Narottam Lamichhane Bobban Subhadra Rahul R. Deshmukh Colorectal cancer (CRC) is one of the most common types of cancer worldwide. There are many factors that predispose a patient to the disease...
Cancers, Vol. 12, Pages 1158: Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes Cancers doi: 10.3390/cancers12051158 Authors: Lorena Incorvaia Daniele Fanale Giuseppe Badalamenti Marco Bono Valentina Calò Daniela Cancelliere Marta Castiglia Alessia Fiorino Alessia Pivetti Nadia Barraco Sofia Cutaia Antonio Russo Viviana Bazan Recent advances in...
Cancers, Vol. 12, Pages 1161: Acquired Resistance to Immune Checkpoint Blockade Therapies Cancers doi: 10.3390/cancers12051161 Authors: Xianda Zhao Dechen Wangmo Matthew Robertson Subbaya Subramanian Immune checkpoint blockade therapy (ICBT) has revolutionized the treatment and management of numerous cancers, yet a substantial proportion of patients who initially respond to ICBT subsequently develop resistance. Comprehensive genomic analysis of samples from recent clinical trials...
Cancers, Vol. 12, Pages 1164: Alterations of HPV-Related Biomarkers after Prophylactic HPV Vaccination. A Prospective Pilot Observational Study in Greek Women Cancers doi: 10.3390/cancers12051164 Authors: George Valasoulis Abraham Pouliakis George Michail Christine Kottaridi Aris Spathis Maria Kyrgiou Evangelos Paraskevaidis Alexandros Daponte The objective of this study was to investigate the hypothesis that HPV vaccination administered in patients with low-grade...
Cancers, Vol. 12, Pages 1160: Combination of Withaferin-A and CAPE Provides Superior Anticancer Potency: Bioinformatics and Experimental Evidence to Their Molecular Targets and Mechanism of Action Cancers doi: 10.3390/cancers12051160 Authors: Anissa Nofita Sari Priyanshu Bhargava Jaspreet Kaur Dhanjal Jayarani F. Putri Navaneethan Radhakrishnan Seyad Shefrin Yoshiyuki Ishida Keiji Terao Durai Sundar Sunil C. Kaul Renu Wadhwa We have earlier reported anticancer...
Cancers, Vol. 12, Pages 1159: RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia Cancers doi: 10.3390/cancers12051159 Authors: Franz J. Gassner Nadja Zaborsky Daniel Feldbacher Richard Greil Roland Geisberger Chronic lymphocytic leukemia (CLL) is a high incidence B cell leukemia with a highly variable clinical course, leading to survival times ranging from months to several decades. MicroRNAs (miRNAs) are small non-coding RNAs that regulate the expression levels...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου